OR
NVRO

Olympiad Research’s NEVRO CORP. NVRO Stock Holding History

Olympiad Research’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,046
Closed -$211K – 495
2024
Q2 		$211K Buy
+25,046
New +$267K 0.16% 280
2022
Q3 		$221K Buy
+4,749
New +$220K 0.12% 191
2020
Q3 		– Sell
-3,155
Closed -$377K – 465
2020
Q2 		$377K Buy
+3,155
New +$374K 0.27% 66

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Olympiad Research's NVRO Position: Q3 2024 in Review

Olympiad Research sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 25,046 shares — an estimated $211K sold.

Olympiad Research first reported a position in NVRO in Q2 2020 and held it in 3 quarters. The position peaked at $377K in Q2 2020. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Olympiad Research reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Olympiad Research sold 25,046 NEVRO CORP. shares in Q3 2024, an estimated $211K.
  • Olympiad Research first reported a position in NEVRO CORP. in Q2 2020 and held it in 3 quarters.
  • Olympiad Research's NEVRO CORP. position peaked at $377K in Q2 2020.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on Olympiad Research's 13F filing for Q3 2024, filed 31 Oct 2024.